Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fomepizole for Acetaldehyde Toxicity in ALDH2 Deficiency
NCT00661141Phase 2Completed
- Sponsor
- Amgen
- Start
- Apr 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fomepizole in aldehyde dehydrogenase 2 deficiency (4 cohorts), sponsored by Amgen. Primary endpoint: Number of Participants With Adverse Events. Started Apr 2008; status: completed.
02
Drugs
fomepizole
03
Conditions
aldehyde dehydrogenase 2 deficiency
Beyond the preview
Go deeper on NCT00661141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661141.